Cargando…

Should Liver Transplants be Performed for Malignant Disease?

Detalles Bibliográficos
Autores principales:	Hobbs, K. E. F., Pitt, Henry A.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1989
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2423525/ https://www.ncbi.nlm.nih.gov/pubmed/2487390 http://dx.doi.org/10.1155/1989/17497

Ejemplares similares

Liver transplantation in hepatocellular carcinoma – should we perform downstaging?
por: Filipec Kanižaj, Tajana, et al.
Publicado: (2022)

Liver transplantation in malignant disease
por: Lang, Sven Arke, et al.
Publicado: (2021)

Liver transplantation for malignancy.
por: London, N. J., et al.
Publicado: (1991)

Liver Transplantation: Practice and Management
por: Hobbs, K E F
Publicado: (1994)

Liver Transplantation: What Every Gastroenterologist Should Know about It
por: Saidi, Reza F.
Publicado: (2018)

A Recipient and Donor Both Have COVID-19 Disease. Should We Perform a Liver Transplant?
por: Tuncer, Adem, et al.
Publicado: (2021)

Should Portasystemic Shunts be Avoided in Potential Liver Transplant Candidates?
por: Emond, Jean C., et al.
Publicado: (1990)

Thrombocytopenia after liver transplantation: Should we care?
por: Takahashi, Kazuhiro, et al.
Publicado: (2018)

Should AI allocate livers for transplant? Public attitudes and ethical considerations
por: Drezga-Kleiminger, Max, et al.
Publicado: (2023)

PRO: Liver Transplantation in the Times of COVID‐19: Patients with COVID‐19 Infection Should Undergo Liver Transplantation
por: Nickerson, Ashley M., et al.
Publicado: (2021)

Role of nitric oxide in liver transplantation: Should it be routinely used?
por: Fukazawa, Kyota, et al.
Publicado: (2016)

Should we use liver grafts repeatedly refused by other transplant teams?
por: Winter, Audrey, et al.
Publicado: (2020)

Ethics of split liver transplantation: should a large liver always be split if medically safe?
por: Kim, Tae Wan, et al.
Publicado: (2022)

CON: Liver Transplantation in the Times of COVID‐19: Patients with COVID‐19 Infection Should not Undergo Liver Transplantation
por: Whitsett, Maureen, et al.
Publicado: (2021)

Editorial: Transplant Oncology of Liver Malignancies
por: Ho, Cheng-Maw
Publicado: (2022)

Liver Transplantation for Hepatocellular Carcinoma: How Should We Improve the Thresholds?
por: Shimamura, Tsuyoshi, et al.
Publicado: (2022)

Should Cell Salvage Be Used in Liver Resection and Transplantation? A Systematic Review and Meta-analysis
por: Rajendran, Luckshi, et al.
Publicado: (2023)

Should We Exclude Live Donor Liver Transplantation for Liver Transplant Recipients Requiring Mechanical Ventilation and Intensive Care Unit Care?
por: Goldaracena, Nicolas, et al.
Publicado: (2015)

P-027: SICKLE CELL DISEASE AND AUTOIMMUNE LIVER DISORDERS: SHOULD HEMATOPOIETIC STEM CELL TRANSPLANTATION BE DISCUSSED EARLY?
por: F., LACAILLE, et al.
Publicado: (2022)

Orthotopic Liver Transplantation in a Patient with Acutely Decompensated Liver Disease and Personal History of Malignant Hyperthermia
por: Townsend, Elizabeth A., et al.
Publicado: (2022)

Post-Transplant Malignancy in Liver Transplantation: A Single Center Experience
Publicado: (2015)

Post-Transplant Malignancy in Liver Transplantation: A Single Center Experience
por: Hsiao, Chih-Yang, et al.
Publicado: (2014)

Liver Transplantation for Intrahepatic Cholangiocarcinoma: What Are New Insights and What Should We Follow?
por: Sun, Dawei, et al.
Publicado: (2022)

Updates and Expert Opinions on Liver Transplantation for Gastrointestinal Malignancies
por: Shannon, Alexander H., et al.
Publicado: (2023)

Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation
por: Park, Gil-Chun, et al.
Publicado: (2020)

Should uterus transplants be publicly funded?
por: Wilkinson, Stephen, et al.
Publicado: (2016)

Panic in the Pandemic: When Should Kidney Transplant Programs Close?
por: Vinson, Amanda J., et al.
Publicado: (2021)

Heart and kidney transplant: should they be combined or subsequent?
por: Melvinsdottir, Inga, et al.
Publicado: (2020)

Individualized Immunosuppressive Protocol of Liver Transplant Recipient Should be Made Based on Splenic Function Status
por: Song, Ji-Yong, et al.
Publicado: (2016)

Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report
por: Houben, Philipp, et al.
Publicado: (2021)

How should cancer presenting as a malignant pleural effusion be managed?
por: Bonnefoi, H., et al.
Publicado: (1996)

Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening?
por: Khanna, Urmi, et al.
Publicado: (2021)

Myocardial Performance after Successful Liver Transplantation
por: Amoozgar, H., et al.
Publicado: (2016)

Improving Comfort of Patients with Ureteral Obstruction and Malignant Disease Should Be of Concern
por: Vogt, Benoît, et al.
Publicado: (2016)

Results of heart transplantation in the urgent recipient - who should be transplanted?
por: Prieto, David, et al.
Publicado: (2014)

Transplant ureter should be stented routinely
por: Mongha, Ritesh, et al.
Publicado: (2010)

Vascular Multiplicity Should Not Be a Contra-Indication for Live Kidney Donation and Transplantation
por: Lafranca, Jeffrey A., et al.
Publicado: (2016)

Selection of Hepatocellular Carcinoma Patients for Liver Transplantation: Should the Threshold for Expected Oncological Survival Be Lowered?
por: Giacomoni, Alessandro, et al.
Publicado: (2019)

The conclusion of reducing acute rejection after liver transplantation by machine perfusion should be extrapolated with caution
por: Liang, Aijun, et al.
Publicado: (2023)

Indication of Liver Transplantation for Hepatocellular Carcinoma Should Be Reconsidered in Case of Microvascular Invasion and Multilocular Tumor Occurrence
por: Gundlach, Jan-Paul, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6r56lssv8bsh5bpug3o6b4k812